Lonamo Duo

Lonamo Duo combines Metformin Hydrochloride and Sitagliptin Hydrochloride Monohydrate for oral use, offering a dual-action approach to managing blood sugar levels. This medication is designed to support individuals with type 2 diabetes in maintaining healthy glucose levels.

Lonamo Duo is primarily used to manage type 2 diabetes by improving blood sugar control. Metformin Hydrochloride works by reducing glucose production in the liver and improving insulin sensitivity, while Sitagliptin Hydrochloride Monohydrate enhances the body's natural insulin production. This combination is often prescribed for individuals who require both medications to achieve optimal blood sugar levels.

Common effects of Lonamo Duo may include gastrointestinal discomfort, such as nausea, diarrhea, or abdominal pain, particularly when first starting the medication. Some individuals may also experience headaches or a mild metallic taste in the mouth. These effects are generally temporary and may subside as the body adjusts to the medication.

Lonamo Duo should be used with caution in individuals with kidney or liver impairment. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Regular monitoring of blood sugar levels is recommended to ensure the medication's effectiveness and safety.

Lonamo Duo may interact with certain medications, including other diabetes drugs, antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can increase the risk of low blood sugar and other side effects. Always inform your healthcare provider about all medications and supplements you are taking.